Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study.

Suzanne M E Kuijpers Chantal Maria WiepjesElfi B ConemansAlessandra Daphne Fisher Thomas Sloane Guy Martin den Heijer

Published in: The Journal of clinical endocrinology and metabolism (2021)

Compared with higher doses of CPA, a daily dose of 10 mg is equally effective in lowering testosterone concentrations in trans women, while showing fewer side effects.

Keyphrases

polycystic ovary syndrome
pregnancy outcomes
breast cancer risk
pregnant women
replacement therapy